Fabrinet enters June in an unusual position: short sellers have been aggressively adding exposure over the past week, yet the stock just posted its biggest single-day gain in months — a 12.7% surge on June 2 that left the bears temporarily offside.
The short interest story here is the genuine tension. SI has risen 20.7% over the past week, taking the estimated short position to 7.3% of the free float — a meaningful level for a high-quality EMS name that previously traded with far lighter short positioning. The week began with roughly 2.17 million shares short; by the end it had climbed to 2.61 million. That build came even as the stock fell sharply in the preceding days following a post-earnings slide, suggesting active managers were pressing a thesis rather than simply hedging. Then Tuesday's 12.7% rebound scrambled the near-term calculus.
The lending market, however, tells a different story — one that undercuts the bear case on squeeze risk. Availability remains deeply comfortable at 439% of outstanding short interest, meaning there are more than four shares available to borrow for every share already shorted. Borrowing costs are just 0.46% annualised — firmly in the "almost free to short" category. That combination of ample availability and low cost means there is no real mechanical pressure on these short positions. The ORTEX short score of 49.5 reflects exactly this: elevated SI, but no material squeeze setup. The put/call ratio at 1.46 has actually eased from elevated levels seen through April and early May, when it was running above 1.9. Options traders are less defensive now than they were before earnings.
Bulls and bears are debating familiar terrain. Fabrinet delivered a record Q3, but the stock tumbled on the print anyway — falling over 6% on the day results dropped and an additional 5% the following session. That pattern of selling strong results is a recurring feature: across the three most recent earnings events in the data, the stock has dropped an average of around 8% in the first five days after each report. The next earnings event is not until August 17, leaving the next couple of months for the stock to trade on newsflow rather than guidance. Barclays lifted its target sharply to $702 following the Q3 print, keeping its Overweight rating, while JP Morgan maintained a Neutral stance and trimmed its target to $680. Needham stayed firmly in the Buy camp at $800. The Street mean price target of $749 sits roughly 7% above current levels — a thin but positive implied return for a stock trading at 46x trailing earnings and 38.5x EV/EBITDA. Bulls point to Fabrinet's exposure to AI infrastructure via optical interconnects and its expanding manufacturing capacity; bears flag heavy concentration in the optical communications market and the risk that supply chain disruptions at its Thailand facilities dent margins.
On the institutional side, the register is stable and high-quality. BlackRock holds 15.6% of shares and added modestly in April. T. Rowe Price holds 11.4% and was also adding in Q1. American Century stands out as the most active recent builder, adding over 314,000 shares in the period to April 30. These are not names that move in and out quickly. Insider activity in the past three months has been selling-only — independent director Homa Bahrami sold 2,500 shares in late May at just under $712, a level close to where the stock now trades. The net 90-day insider balance works out to a modest disposal in value terms, with all activity coming from board members rather than executives, which tempers the signal somewhat.
The immediate dynamic to watch is whether the short rebuild of the past week continues now that the stock has recovered to the $700 area. With availability loose, borrowing cheap, and the next earnings print more than ten weeks away, the setup is less about squeeze pressure and more about whether the fundamental bear case — customer concentration, optical market saturation — gets any new evidence to work with.
See the live data behind this article on ORTEX.
Open FN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
